Systemic Lupus Erythematosus, An Issue of Rheumatic Disease Clinics - E-Book
Nonfiction, Health & Well Being, Medical, Specialties, Rheumatology
| Author: | Ellen M. Ginzler, MD, MPH | ISBN: | 9781455700639 |
| Publisher: | Elsevier Health Sciences | Publication: | March 31, 2010 |
| Imprint: | Saunders | Language: | English |
| Author: | Ellen M. Ginzler, MD, MPH |
| ISBN: | 9781455700639 |
| Publisher: | Elsevier Health Sciences |
| Publication: | March 31, 2010 |
| Imprint: | Saunders |
| Language: | English |
This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.
This issue brings the rheumatologist on the current thinking on treatment of Systemic Lupus Erythematosus, with an eye to the future. Topics covered include B cell biology and related therapies; glutamate receptor biology and its clinical significance in neuropsychiatric SLE; platelet C4d and vascular complications; biomarkers in lupus nephritis; endothelial function and its implications for cardiovascular and renal disease in SLE; changing worldwide epidemiology of SLE and its relationship to environmental, ethnic, and other sociodemographic factors; work loss, disability, quality of life, and compliance in SLE; pediatric lupus; metabolic syndrome and related endocrine abnormalities; the significance of interferon and the consequences of anti-interferon in SLE; and cutaneous lupus and the CLASI instrument.
